Opto Circuits subsidiary takes a step forward to cater needs of physicians
Opto Circuits (India) Limited declared the commencement of its commercial sale of Freeway 035 long-length DCBs on Tuesday.
Introducing CE marked 19Ornm and 230mm catheters, Eurocor Tech GmbH is the only company to cater to the needs of patients & physicians faced with the treatment of challenging long-term injuries worldwide.
A growing number of patients worldwide suffer from vascular diseases mostly seen in the peripheral areas and a growing number of cases are observed in critical stages. While Drug-coated balloons (DCBs) are considered to be excellent and suitable options, it is equally important to update technologies for sufficiently and optimally treating high-risk patient groups. This new launch also aims at minimal invasive intervention.
India-based global medical devices & technology company, Opto Circuits, and its subsidiaries are engaged in the design, development, manufacture, marketing & distribution of a range of medical products that are used by primary, secondary, and tertiary healthcare establishments, as well as in public access facilities, such as fire stations, policy offices. Eurocor Tech GmbH is a wholly-owned subsidiary of Opto Eurocor Healthcare Limited and is part of Opto Circuits Group.
The share of Opto Circuits (India) Limited was trading at Rs 5.37 during the first half of the trading session on Wednesday which is 3.24 per cent down on BSE.